Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: OPHIREX, INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-06-19 to 2023-06-18
Current total value of award: $10571594
Description: COVID-19 DHA 2018.1 SBIR PHASE III MEDICAL R&D CONTRACT PROPOSAL TITLED: "TARGETING SPLA2 FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ASSOCIATED WITH SARS-COV2" LOG 1900053 INCORPORATION OF REVISED TECHNICAL PROPOSAL/SOW AND BUDGET